Study to Evaluate the Safety and Efficacy of ASC40 Tablets in Combination With Bevacizumab in Subjects With rGBM

NCT05118776 · clinicaltrials.gov ↗

PHASE3

Phase

ACTIVE_NOT_RECRUITING

Status

136

Enrollment

INDUSTRY

Sponsor class

Conditions

Recurrent Glioblastoma

Interventions

DRUG: ASC40 tablets
DRUG: Placebo tablets
DRUG: Bevacizumab

Sponsor

Ascletis Pharmaceuticals Co., Ltd.